The Food and Drug Administration (FDA) will be reviewing an at-home flu vaccine as uptake for the inoculations remains low this year. AstraZeneca announced Tuesday that its needle-free nasal spray was accepted by the FDA for review. If approved, the company said it would be the first self-administered flu vaccine available in the United States, which AstraZeneca said could boost vaccination rates. Iskra Reic, AstraZeneca’s executive vice president of vaccines and immune therapies, said that the nasal spray “could revolutionize flu vaccination.” Reic said that AstraZeneca’s self-administered vaccine would be delivered directly to homes, which he said would be an ‘innovative, more acc
Hence then, the article about fda reviewing at home flu vaccines was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA reviewing at-home flu vaccines )